Global Life Sciences BPO Market

Life Sciences BPO Comprehensive Study by Type (Pharmaceutical Outsourcing (Contract Research Organizations, Contract Manufacturing Organizations, Contract Sales and Marketing Organizations), Others (Payers and Providers)), Contract Research Organizations (Drug Discovery, Preclinical Studies, Clinical Trials, Medical Writing, Pharmacovigilance, Clinical Data Management, Regulatory Services, Clinical Monitoring, Biostatistics, Protocol Development, Site Management), Contract Manufacturing Organizations (Active Pharmaceutical Ingredients, Finished Dose Form Manufacturing, Packaging) Players and Region - Global Market Outlook to 2030

Life Sciences BPO Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Life Sciences BPO
Favorable government initiatives to inspire the use of generic drugs, several tax benefits to promote the export of life sciences services from this region, and subsidies for the manufacturing of electronic components and devices, are anticipated to further propel the market growth over the forecast period. Growing demand for outsourcing services related to drug discovery, clinical trials, clinical data management, pharmacovigilance, and regulatory consulting will boost the demand for life science BPO market globally.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)


The global life science BPO market is very fragmented and the key players have used many strategies including new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their market share in this market. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Life Sciences BPO market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Accenture plc (Ireland), Anthelio Healthcare Solutions (United States), Covance, Inc. (United States), Genpact Ltd. (United States), Boehringer Ingelheim GmbH (Germany), Catalent, Inc. (United States), ICON plc (Ireland), Infosys Limited (India), Lonza Group (Switzerland) and PAREXEL International Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Quintiles Transnational Corporation (United States) and International Business Machines Corporation (United States).

Segmentation Overview
AMA Research has segmented the market of Global Life Sciences BPO market by Type (Pharmaceutical Outsourcing [Contract Research Organizations, Contract Manufacturing Organizations, Contract Sales and Marketing Organizations] and Others (Payers and Providers)) and Region.



On the basis of geography, the market of Life Sciences BPO has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Contract Research Organizations, the sub-segment i.e. Drug Discovery will boost the Life Sciences BPO market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Contract Manufacturing Organizations, the sub-segment i.e. Active Pharmaceutical Ingredients will boost the Life Sciences BPO market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Favorable Government Initiatives Such As the Introduction of ICD-10 Standards, The Increasing Adoption of Electronic Health Record Systems (EHR) and The Rising Demand for Biosimilar Drugs

Market Growth Drivers:
The Increasing Pool of Geriatric Patients and The High Prevalence of Chronic Ailments

Challenges:
Rising Data Security Threats and Strict Government Regulations

Restraints:
High Cost of Raw Material and Quality of Service

Opportunities:
Growing Sales and Marketing Activities for the New Product Launches and Rising Demand of BPO in Emerging Countries

In November 2019, Syneos Health, Inc collaborated with Aicure and AI to gain the position in the market with developments like advance data analytics company for success trials.
In the United States, The Health Insurance Portability and Accountability Act (HIPAA) was settled to protect the confidentiality of a patient’s medical evidence and to safeguard persons' medical records and private health-related data. It sets a boundary on the use and the release of health records.

Key Target Audience
Healthcare Service Providers, Teaching Hospitals and Academic Medical Centers (AMCs), Health Insurance Players, Investment Research Firms, Government and Private Research Organization, Government Regulatory Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Pharmaceutical Outsourcing [Contract Research Organizations, Contract Manufacturing Organizations, Contract Sales and Marketing Organizations]
  • Others (Payers and Providers)
By Contract Research Organizations
  • Drug Discovery
  • Preclinical Studies
  • Clinical Trials
  • Medical Writing
  • Pharmacovigilance
  • Clinical Data Management
  • Regulatory Services
  • Clinical Monitoring
  • Biostatistics
  • Protocol Development
  • Site Management

By Contract Manufacturing Organizations
  • Active Pharmaceutical Ingredients
  • Finished Dose Form Manufacturing
  • Packaging

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Increasing Pool of Geriatric Patients
      • 3.2.2. The High Prevalence of Chronic Ailments
    • 3.3. Market Challenges
      • 3.3.1. Rising Data Security Threats
      • 3.3.2. Strict Government Regulations
    • 3.4. Market Trends
      • 3.4.1. Favorable Government Initiatives Such As the Introduction of ICD-10 Standards
      • 3.4.2. The Increasing Adoption of Electronic Health Record Systems (EHR)
      • 3.4.3. The Rising Demand for Biosimilar Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Life Sciences BPO, by Type, Contract Research Organizations, Contract Manufacturing Organizations and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Life Sciences BPO (Value)
      • 5.2.1. Global Life Sciences BPO by: Type (Value)
        • 5.2.1.1. Pharmaceutical Outsourcing [Contract Research Organizations, Contract Manufacturing Organizations, Contract Sales and Marketing Organizations]
        • 5.2.1.2. Others (Payers and Providers)
      • 5.2.2. Global Life Sciences BPO by: Contract Research Organizations (Value)
        • 5.2.2.1. Drug Discovery
        • 5.2.2.2. Preclinical Studies
        • 5.2.2.3. Clinical Trials
        • 5.2.2.4. Medical Writing
        • 5.2.2.5. Pharmacovigilance
        • 5.2.2.6. Clinical Data Management
        • 5.2.2.7. Regulatory Services
        • 5.2.2.8. Clinical Monitoring
        • 5.2.2.9. Biostatistics
        • 5.2.2.10. Protocol Development
        • 5.2.2.11. Site Management
      • 5.2.3. Global Life Sciences BPO by: Contract Manufacturing Organizations (Value)
        • 5.2.3.1. Active Pharmaceutical Ingredients
        • 5.2.3.2. Finished Dose Form Manufacturing
        • 5.2.3.3. Packaging
      • 5.2.4. Global Life Sciences BPO Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Life Sciences BPO: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Accenture plc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Anthelio Healthcare Solutions (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Covance, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Genpact Ltd. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Boehringer Ingelheim GmbH (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Catalent, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ICON plc (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Infosys Limited (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lonza Group (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PAREXEL International Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Life Sciences BPO Sale, by Type, Contract Research Organizations, Contract Manufacturing Organizations and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Life Sciences BPO (Value)
      • 7.2.1. Global Life Sciences BPO by: Type (Value)
        • 7.2.1.1. Pharmaceutical Outsourcing [Contract Research Organizations, Contract Manufacturing Organizations, Contract Sales and Marketing Organizations]
        • 7.2.1.2. Others (Payers and Providers)
      • 7.2.2. Global Life Sciences BPO by: Contract Research Organizations (Value)
        • 7.2.2.1. Drug Discovery
        • 7.2.2.2. Preclinical Studies
        • 7.2.2.3. Clinical Trials
        • 7.2.2.4. Medical Writing
        • 7.2.2.5. Pharmacovigilance
        • 7.2.2.6. Clinical Data Management
        • 7.2.2.7. Regulatory Services
        • 7.2.2.8. Clinical Monitoring
        • 7.2.2.9. Biostatistics
        • 7.2.2.10. Protocol Development
        • 7.2.2.11. Site Management
      • 7.2.3. Global Life Sciences BPO by: Contract Manufacturing Organizations (Value)
        • 7.2.3.1. Active Pharmaceutical Ingredients
        • 7.2.3.2. Finished Dose Form Manufacturing
        • 7.2.3.3. Packaging
      • 7.2.4. Global Life Sciences BPO Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Life Sciences BPO: by Type(USD Million)
  • Table 2. Life Sciences BPO Pharmaceutical Outsourcing [Contract Research Organizations, Contract Manufacturing Organizations, Contract Sales and Marketing Organizations] , by Region USD Million (2018-2023)
  • Table 3. Life Sciences BPO Others (Payers and Providers) , by Region USD Million (2018-2023)
  • Table 4. Life Sciences BPO: by Contract Research Organizations(USD Million)
  • Table 5. Life Sciences BPO Drug Discovery , by Region USD Million (2018-2023)
  • Table 6. Life Sciences BPO Preclinical Studies , by Region USD Million (2018-2023)
  • Table 7. Life Sciences BPO Clinical Trials , by Region USD Million (2018-2023)
  • Table 8. Life Sciences BPO Medical Writing , by Region USD Million (2018-2023)
  • Table 9. Life Sciences BPO Pharmacovigilance , by Region USD Million (2018-2023)
  • Table 10. Life Sciences BPO Clinical Data Management , by Region USD Million (2018-2023)
  • Table 11. Life Sciences BPO Regulatory Services , by Region USD Million (2018-2023)
  • Table 12. Life Sciences BPO Clinical Monitoring , by Region USD Million (2018-2023)
  • Table 13. Life Sciences BPO Biostatistics , by Region USD Million (2018-2023)
  • Table 14. Life Sciences BPO Protocol Development , by Region USD Million (2018-2023)
  • Table 15. Life Sciences BPO Site Management , by Region USD Million (2018-2023)
  • Table 16. Life Sciences BPO: by Contract Manufacturing Organizations(USD Million)
  • Table 17. Life Sciences BPO Active Pharmaceutical Ingredients , by Region USD Million (2018-2023)
  • Table 18. Life Sciences BPO Finished Dose Form Manufacturing , by Region USD Million (2018-2023)
  • Table 19. Life Sciences BPO Packaging , by Region USD Million (2018-2023)
  • Table 20. South America Life Sciences BPO, by Country USD Million (2018-2023)
  • Table 21. South America Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 22. South America Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 23. South America Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 24. Brazil Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 25. Brazil Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 26. Brazil Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 27. Argentina Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 28. Argentina Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 29. Argentina Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 30. Rest of South America Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 31. Rest of South America Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 32. Rest of South America Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 33. Asia Pacific Life Sciences BPO, by Country USD Million (2018-2023)
  • Table 34. Asia Pacific Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 35. Asia Pacific Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 36. Asia Pacific Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 37. China Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 38. China Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 39. China Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 40. Japan Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 41. Japan Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 42. Japan Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 43. India Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 44. India Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 45. India Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 46. South Korea Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 47. South Korea Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 48. South Korea Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 49. Taiwan Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 50. Taiwan Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 51. Taiwan Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 52. Australia Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 53. Australia Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 54. Australia Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 55. Rest of Asia-Pacific Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 56. Rest of Asia-Pacific Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 57. Rest of Asia-Pacific Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 58. Europe Life Sciences BPO, by Country USD Million (2018-2023)
  • Table 59. Europe Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 60. Europe Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 61. Europe Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 62. Germany Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 63. Germany Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 64. Germany Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 65. France Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 66. France Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 67. France Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 68. Italy Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 69. Italy Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 70. Italy Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 71. United Kingdom Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 72. United Kingdom Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 73. United Kingdom Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 74. Netherlands Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 75. Netherlands Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 76. Netherlands Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 77. Rest of Europe Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 78. Rest of Europe Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 79. Rest of Europe Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 80. MEA Life Sciences BPO, by Country USD Million (2018-2023)
  • Table 81. MEA Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 82. MEA Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 83. MEA Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 84. Middle East Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 85. Middle East Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 86. Middle East Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 87. Africa Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 88. Africa Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 89. Africa Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 90. North America Life Sciences BPO, by Country USD Million (2018-2023)
  • Table 91. North America Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 92. North America Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 93. North America Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 94. United States Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 95. United States Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 96. United States Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 97. Canada Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 98. Canada Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 99. Canada Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 100. Mexico Life Sciences BPO, by Type USD Million (2018-2023)
  • Table 101. Mexico Life Sciences BPO, by Contract Research Organizations USD Million (2018-2023)
  • Table 102. Mexico Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2018-2023)
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Life Sciences BPO: by Type(USD Million)
  • Table 114. Life Sciences BPO Pharmaceutical Outsourcing [Contract Research Organizations, Contract Manufacturing Organizations, Contract Sales and Marketing Organizations] , by Region USD Million (2025-2030)
  • Table 115. Life Sciences BPO Others (Payers and Providers) , by Region USD Million (2025-2030)
  • Table 116. Life Sciences BPO: by Contract Research Organizations(USD Million)
  • Table 117. Life Sciences BPO Drug Discovery , by Region USD Million (2025-2030)
  • Table 118. Life Sciences BPO Preclinical Studies , by Region USD Million (2025-2030)
  • Table 119. Life Sciences BPO Clinical Trials , by Region USD Million (2025-2030)
  • Table 120. Life Sciences BPO Medical Writing , by Region USD Million (2025-2030)
  • Table 121. Life Sciences BPO Pharmacovigilance , by Region USD Million (2025-2030)
  • Table 122. Life Sciences BPO Clinical Data Management , by Region USD Million (2025-2030)
  • Table 123. Life Sciences BPO Regulatory Services , by Region USD Million (2025-2030)
  • Table 124. Life Sciences BPO Clinical Monitoring , by Region USD Million (2025-2030)
  • Table 125. Life Sciences BPO Biostatistics , by Region USD Million (2025-2030)
  • Table 126. Life Sciences BPO Protocol Development , by Region USD Million (2025-2030)
  • Table 127. Life Sciences BPO Site Management , by Region USD Million (2025-2030)
  • Table 128. Life Sciences BPO: by Contract Manufacturing Organizations(USD Million)
  • Table 129. Life Sciences BPO Active Pharmaceutical Ingredients , by Region USD Million (2025-2030)
  • Table 130. Life Sciences BPO Finished Dose Form Manufacturing , by Region USD Million (2025-2030)
  • Table 131. Life Sciences BPO Packaging , by Region USD Million (2025-2030)
  • Table 132. South America Life Sciences BPO, by Country USD Million (2025-2030)
  • Table 133. South America Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 134. South America Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 135. South America Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 136. Brazil Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 137. Brazil Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 138. Brazil Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 139. Argentina Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 140. Argentina Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 141. Argentina Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 142. Rest of South America Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 143. Rest of South America Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 144. Rest of South America Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 145. Asia Pacific Life Sciences BPO, by Country USD Million (2025-2030)
  • Table 146. Asia Pacific Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 147. Asia Pacific Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 148. Asia Pacific Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 149. China Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 150. China Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 151. China Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 152. Japan Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 153. Japan Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 154. Japan Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 155. India Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 156. India Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 157. India Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 158. South Korea Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 159. South Korea Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 160. South Korea Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 161. Taiwan Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 162. Taiwan Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 163. Taiwan Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 164. Australia Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 165. Australia Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 166. Australia Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 167. Rest of Asia-Pacific Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 168. Rest of Asia-Pacific Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 169. Rest of Asia-Pacific Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 170. Europe Life Sciences BPO, by Country USD Million (2025-2030)
  • Table 171. Europe Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 172. Europe Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 173. Europe Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 174. Germany Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 175. Germany Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 176. Germany Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 177. France Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 178. France Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 179. France Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 180. Italy Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 181. Italy Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 182. Italy Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 183. United Kingdom Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 184. United Kingdom Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 185. United Kingdom Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 186. Netherlands Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 187. Netherlands Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 188. Netherlands Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 189. Rest of Europe Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 190. Rest of Europe Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 191. Rest of Europe Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 192. MEA Life Sciences BPO, by Country USD Million (2025-2030)
  • Table 193. MEA Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 194. MEA Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 195. MEA Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 196. Middle East Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 197. Middle East Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 198. Middle East Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 199. Africa Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 200. Africa Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 201. Africa Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 202. North America Life Sciences BPO, by Country USD Million (2025-2030)
  • Table 203. North America Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 204. North America Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 205. North America Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 206. United States Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 207. United States Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 208. United States Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 209. Canada Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 210. Canada Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 211. Canada Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 212. Mexico Life Sciences BPO, by Type USD Million (2025-2030)
  • Table 213. Mexico Life Sciences BPO, by Contract Research Organizations USD Million (2025-2030)
  • Table 214. Mexico Life Sciences BPO, by Contract Manufacturing Organizations USD Million (2025-2030)
  • Table 215. Research Programs/Design for This Report
  • Table 216. Key Data Information from Secondary Sources
  • Table 217. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Life Sciences BPO: by Type USD Million (2018-2023)
  • Figure 5. Global Life Sciences BPO: by Contract Research Organizations USD Million (2018-2023)
  • Figure 6. Global Life Sciences BPO: by Contract Manufacturing Organizations USD Million (2018-2023)
  • Figure 7. South America Life Sciences BPO Share (%), by Country
  • Figure 8. Asia Pacific Life Sciences BPO Share (%), by Country
  • Figure 9. Europe Life Sciences BPO Share (%), by Country
  • Figure 10. MEA Life Sciences BPO Share (%), by Country
  • Figure 11. North America Life Sciences BPO Share (%), by Country
  • Figure 12. Global Life Sciences BPO share by Players 2023 (%)
  • Figure 13. Global Life Sciences BPO share by Players (Top 3) 2023(%)
  • Figure 14. Global Life Sciences BPO share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Accenture plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 17. Accenture plc (Ireland) Revenue: by Geography 2023
  • Figure 18. Anthelio Healthcare Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 19. Anthelio Healthcare Solutions (United States) Revenue: by Geography 2023
  • Figure 20. Covance, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Covance, Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Genpact Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Genpact Ltd. (United States) Revenue: by Geography 2023
  • Figure 24. Boehringer Ingelheim GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Boehringer Ingelheim GmbH (Germany) Revenue: by Geography 2023
  • Figure 26. Catalent, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Catalent, Inc. (United States) Revenue: by Geography 2023
  • Figure 28. ICON plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 29. ICON plc (Ireland) Revenue: by Geography 2023
  • Figure 30. Infosys Limited (India) Revenue, Net Income and Gross profit
  • Figure 31. Infosys Limited (India) Revenue: by Geography 2023
  • Figure 32. Lonza Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 33. Lonza Group (Switzerland) Revenue: by Geography 2023
  • Figure 34. PAREXEL International Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. PAREXEL International Corporation (United States) Revenue: by Geography 2023
  • Figure 36. Global Life Sciences BPO: by Type USD Million (2025-2030)
  • Figure 37. Global Life Sciences BPO: by Contract Research Organizations USD Million (2025-2030)
  • Figure 38. Global Life Sciences BPO: by Contract Manufacturing Organizations USD Million (2025-2030)
  • Figure 39. South America Life Sciences BPO Share (%), by Country
  • Figure 40. Asia Pacific Life Sciences BPO Share (%), by Country
  • Figure 41. Europe Life Sciences BPO Share (%), by Country
  • Figure 42. MEA Life Sciences BPO Share (%), by Country
  • Figure 43. North America Life Sciences BPO Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Accenture plc (Ireland)
  • Anthelio Healthcare Solutions (United States)
  • Covance, Inc. (United States)
  • Genpact Ltd. (United States)
  • Boehringer Ingelheim GmbH (Germany)
  • Catalent, Inc. (United States)
  • ICON plc (Ireland)
  • Infosys Limited (India)
  • Lonza Group (Switzerland)
  • PAREXEL International Corporation (United States)
Additional players considered in the study are as follows:
Quintiles Transnational Corporation (United States) , International Business Machines Corporation (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 226 Pages 88 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Life Sciences BPO Market Quantitative research analysis
Global Life Sciences BPO Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Accenture plc (Ireland), Anthelio Healthcare Solutions (United States), Covance, Inc. (United States), Genpact Ltd. (United States), Boehringer Ingelheim GmbH (Germany), Catalent, Inc. (United States), ICON plc (Ireland), Infosys Limited (India), Lonza Group (Switzerland) and PAREXEL International Corporation (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Favorable Government Initiatives Such As the Introduction of ICD-10 Standards " is seen as one of major influencing trends for Life Sciences BPO Market during projected period 2023-2030.
The Life Sciences BPO market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Life Sciences BPO Market Report?

Have a Query? Click Here

Other Related Reports

Outpatient Home Therapy Comprehensive Study by Type (Physical Therapy {Orthopedic, Geriatric, Neurological, Cardiopulmonary and Pulmonary, Other}, Speech Therapy { Speech Disorder, Language Disorder,...
$ 3650
Oral Health Care Comprehensive Study by Type (Breath Fresheners, Dental Floss, Denture Care, Mouthwashes and Rinses, Toothbrushes and Replacements, Toothpaste (Pastes, Gels, Powders, Polishes)), Appl...
$ 3650
Homecare Telehealth Comprehensive Study by Type (External Remote Patient Monitoring Devices, Implantable Remote Patient Monitoring Devices), Application (Home, Hospital), Services (Telepathology, Tel...
$ 3450
Tooth Regeneration Comprehensive Study by Application (Enamel, Dentin, Pulp), Population Demographic (Geriatrics, Middle Aged, Adult) Players and Region - Global Market Outlook to 2027
$ 3650
Sleep Testing Services Comprehensive Study by Application (In-Lab Sleep Testing, Home Sleep Testing), Service Type (Diagnostic Services, Treatment Monitoring), End User (Hospitals, Sleep Centers, Hom...
$ 3500
Skin Rejuvenation Comprehensive Study by Type (Naturally, Cosmetics & Medicine, Using Devices), End-User (Dermatology Clinics, Beauty Clinics, Aesthetic Service Centers, Others), Treatment Type (Wrin...
$ 3750